FDA Drug Application (021726) for NIRAVAM by UCB INC

Back to FDA Applications sponsored by UCB INC

Application Number021726
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNIRAVAM
Active IngredientALPRAZOLAM



Back to FDA Applications sponsored by UCB INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.